Lawrence Einhorn

966 total citations
21 papers, 700 citations indexed

About

Lawrence Einhorn is a scholar working on Surgery, Oncology and Neurology. According to data from OpenAlex, Lawrence Einhorn has authored 21 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Oncology and 6 papers in Neurology. Recurrent topics in Lawrence Einhorn's work include Testicular diseases and treatments (10 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (4 papers). Lawrence Einhorn is often cited by papers focused on Testicular diseases and treatments (10 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (4 papers). Lawrence Einhorn collaborates with scholars based in United States, Austria and United Kingdom. Lawrence Einhorn's co-authors include Michael A. Burgess, Nasser H. Hanna, Jordan U. Gutterman, Giora M. Mavligit, Emil J. Freireich, Jeffrey A. Gottlieb, Evan M. Hersh, Ramaswamy Govindan, Anton Melnyk and Donald Richards and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Lawrence Einhorn

20 papers receiving 659 citations

Peers

Lawrence Einhorn

PRM

ONCOL

SURGE

MB

IMMUN

Jeffrey Schneider United States

Michiyo Miyawaki Japan

Virag Dandekar United States

Colin Trask United Kingdom

O Van Cutsem Belgium

Giulio Bertola Italy

C. Norman Coleman United States

Sven‐Börje Ewers Sweden

E Lopez-Hänninen Germany

Edson Pontes United States

Jeffrey Schneider United States

Lawrence Einhorn

160 ×0.4

PRM

592 ×1.7

ONCOL

120 ×0.7

SURGE

132 ×1.4

MB

126 ×1.7

IMMUN

Citations per year, relative to Lawrence Einhorn Lawrence Einhorn (= 1×) peers Jeffrey Schneider

Countries citing papers authored by Lawrence Einhorn

Since Specialization

Citations

This map shows the geographic impact of Lawrence Einhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Einhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Einhorn more than expected).

Fields of papers citing papers by Lawrence Einhorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Einhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Einhorn. The network helps show where Lawrence Einhorn may publish in the future.

Co-authorship network of co-authors of Lawrence Einhorn

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Einhorn. A scholar is included among the top collaborators of Lawrence Einhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Einhorn. Lawrence Einhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Brames, Mary J., Giorgio Papiani, & Lawrence Einhorn. (2007). Results with salvage chemotherapy with high dose carboplatin + etoposide and peripheral blood stem cell transplant in male choriocarcinoma. Journal of Clinical Oncology. 25(18_suppl). 5091–5091. 1 indexed citations

2.

Hanna, Nasser H., Sofia Paul, Frank V. Fossella, et al.. (2003). O-5 Multiple regression analysis of prognostic variables for survival from the phase III study of pemetrexed versus docetaxel in non-small-cell lung cancer (NSCLC). Lung Cancer. 41. S5–S6. 5 indexed citations

3.

Bokemeyer, Carsten, Alan Horwich, A. Gerl, et al.. (2001). Extragonadal seminoma. Cancer. 91(7). 1394–1401. 1 indexed citations

4.

Hartmann, Jörg T., Craig R. Nichols, A. Horwich, et al.. (2000). The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer. 88(11). 2629–2635.

5.

Sweeney, Christopher J., et al.. (2000). RISK OF SYSTEMIC METASTASES IN CLINICAL STAGE I NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTION. The Journal of Urology. 1721–1724. 4 indexed citations

6.

Nichols, Craig R., A. Horwich, A. Gerl, et al.. (2000). The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer. 88(11). 2629–2635. 23 indexed citations

7.

Sweeney, Christopher J., et al.. (2000). RISK OF SYSTEMIC METASTASES IN CLINICAL STAGE I NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTION. The Journal of Urology. 163(6). 1721–1724. 70 indexed citations

8.

Donohue, John P., et al.. (1996). Biology of metastases and its clinical implications: testicular germ-cell tumors. World Journal of Urology. 14(3). 197–203. 5 indexed citations

9.

Loehrer, P. J., et al.. (1992). Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer. Lung Cancer. 8(3-4). 240–240. 1 indexed citations

10.

Einhorn, Lawrence. (1992). Approaches to drug therapy in older cancer patients.. PubMed. 6(2 Suppl). 69–73. 4 indexed citations

11.

Einhorn, Lawrence. (1992). Current perspectives on the use of etoposide. Introduction.. PubMed. 19(6 Suppl 13). 1–2. 1 indexed citations

12.

Williams, Stephen D., Patrick J. Loehrer, C R Nichols, Bruce J. Roth, & Lawrence Einhorn. (1989). Disseminated testicular cancer: current chemotherapy strategies.. PubMed. 16(4 Suppl 6). 105–9. 9 indexed citations

13.

Roth, Bruce J., Lawrence Einhorn, & Anne Greist. (1988). Long-term complications of cisplatin-based chemotherapy for testis cancer.. PubMed. 15(4). 345–50. 34 indexed citations

14.

Walther, Philip, Stephen D. Williams, M. Troner, et al.. (1986). Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.. PubMed. 70(11). 1337–8. 7 indexed citations

15.

Walther, Philip, et al.. (1986). Phase II study of etoposide for carcinoma of the prostate.. PubMed. 70(6). 771–2. 11 indexed citations

16.

Allegra, Joseph C., Joseph Bertino, Philip Bonomi, et al.. (1985). Metastatic breast cancer: preliminary results with oral hormonal therapy.. PubMed. 12(4 Suppl 6). 61–4. 15 indexed citations

17.

Williams, Stephen D. & Lawrence Einhorn. (1982). Cis-platinum in the treatment of testicular and other cancers.. PubMed. 27. 531–45. 8 indexed citations

18.

Shidnia, Homayoon, et al.. (1978). Total-Body Irradiation with 25-MV Photons in Advanced Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Radiology. 128(2). 503–505. 2 indexed citations

19.

Einhorn, Lawrence, et al.. (1977). Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.. PubMed. 61(5). 881–3. 16 indexed citations

20.

Gutterman, Jordan U., Giora M. Mavligit, Jeffrey A. Gottlieb, et al.. (1974). Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin. New England Journal of Medicine. 291(12). 592–597. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact